Application of purging biotinylated liposomes from plasma to elucidate influx and efflux processes associated with accumulation of liposomes in solid tumors

Biochimica et Biophysica Acta - Biomembranes

Volumn 1611, Issue 1-2, 2003, Pages 63-69

  Fung, Vincent W H ^b   Chiu, Gigi N C ^b   Mayer, Lawrence D ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b NONE

Author keywords

Biotin avidin technology; Drug delivery; Liposome; Pharmacokinetics; Tumor accumulation

Indexed keywords

1,2 DISTEAROYLGLYCERO 3 PHOSPHOCHOLINE; AVIDIN; BIOTIN; CHOLESTEROL; LIPOSOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG TRANSPORT; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SOLID TUMOR;

EID: 0037377317     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(02)00704-6     Document Type: Article

References (20)

1. Mayer L.D., Tai L.C., Ko D.S., Masin D., Ginsberg R.S., Cullis P.R., Bally M.B. Cancer Res. 49:1989;5922-5930.
2. Wu N.Z., Da D., Rudoll T.L., Needham D., Whorton A.R., Dewhirst M.W. Cancer Res. 53:1993;3765-3770.
3. Yuan F., Leunig M., Huang S.K., Berk D.A., Papahadjopoulos D., Jain R.K. Cancer Res. 54:1994;3352-3356.
4. Mayer L.D., Dougherty G., Harasym T.O., Bally M.B. J. Pharmacol. Exp. Ther. 280:1997;1406-1414.
5. Parr M.J., Masin D., Cullis P.R., Bally M.B. J. Pharmacol. Exp. Ther. 280:1997;1319-1327.
6. Hong R.L., Huang C.J., Tseng Y.L., Pang V.F., Chen S.T., Liu J.J., Chang F.H. Clin. Cancer Res. 5:1999;3645-3652.
7. Ogihara-Umeda I., Sasaki T., Nishigori H. Eur. J. Nucl. Med. 20:1993;170-172.
8. Ogihara-Umeda I., Sasaki T., Toyama H., Oda K., Senda M., Nishigori H. Cancer Res. 54:1994;463-467.
9. Ogihara-Umeda I., Sasaki T., Toyama H., Oda K., Senda M., Nishigori H. Cancer Detec. Prev. 21:1997;490-496.
10. Hope M.J., Bally M.B., Webb G., Cullis P.R. Biochim. Biophys. Acta. 812:1985;55-65.
11. Mayer L.D., Hope M.J., Cullis P.R., Janoff A.S. Biochim. Biophys. Acta. 817:1985;193-196.
12. Mayer L.D., Hope M.J., Cullis P.R. Biochim. Biophys. Acta. 858:1986;161-168.
13. Derksen J.T., Morselt H.W., Scherphof G.L. Biochim. Biophys. Acta. 931:1987;33-40.
14. Bally M.B., Mayer L.D., Hope M.J., Nayar R. Gregoriadis G. 2nd ed. Liposome Technology. vol. 3:1993;27-41 CRC Press, Boca Raton, FL.
15. Corley P., Loughrey H.C. Biochim. Biophys. Acta. 1195:1994;149-156.
16. Hiller Y., Gershoni J.M., Bayer E.A., Wilchek M. Biochem. J. 248:1987;167-171.
17. Hobbs S.K., Monsky W.L., Yuan F., Roberts W.G., Griffith L., Torchilin V.P., Jain R.K. Proc. Natl. Acad. Sci. U. S. A. 95:1998;4607-4612.
18. Kang Y.S., Saito Y., Pardridge W.M. J. Drug Target. 3:1995;159-165.
19. Boucher Y., Jain R.K. Cancer Res. 52:1992;5110-5114.
20. Jain R.K. Teicher B.A. Drug Resistance in Oncology. 1993;87-105 Marcel Dekker, New York.